BBB delivery platform for CNS Alzheimer's therapies
Search documents
Lunai Bioworks Executes $20M Strategic Transaction at Fixed $1.50 Conversion, Acquiring BBB Delivery Platform for CNS Alzheimer's Therapies with Broad CNS Delivery Applications
Prnewswire· 2026-03-26 12:50
<!doctype html> <!-- For structured data --> <!-- For language declaration --> Lunai Bioworks Executes $20M Strategic Transaction at Fixed $1.50 Conversion, Acquiring BBB Delivery Platform for CNS Alzheimer's Therapies with Broad CNS Delivery Applications <!-- Additional Authorable Meta tags --> Accessibility StatementSkip NavigationSACRAMENTO, Calif., March 26, 2026 /PRNewswire/ -- Lunai Bioworks, Inc. (NASDAQ: LNAI) today announced it has executed a binding $20 million strategic transaction to acquire blo ...